Search Results 91-100 of 17582 for cannabis

  1. Individualized Pharmacological Approach To Obesity In Patients With Bipolar Disorder - Mayo Clinic

    * Positive toxicology screen for cannabis and a cannabis use disorder by CUDIT-R. * Participants who use cannabis for recreational or medicinal purposes and ...

  2. ¿Es peligroso consumir cannabidiol? Video Audio Dr. Brent Bauer Medicina Integrada Mayo Clinic “El

    “El CBD proviene de la Cannabis sativa, planta de la que se obtiene la marihuana que contiene el THC, sustancia que causa el efecto de euforia en la gente”.

  3. The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression. - Mayo Clinic

    A cannabis use disorder by DSM-5 criteria in partial remission of less than 3 months will be an exclusion from enrollment. Cannabis use disorders in partial ...

  4. Buerger disease - Symptoms and causes - Mayo Clinic

    Some research says that long-term use of marijuana, also called cannabis, also raises the risk of blood vessel problems similar to those of Buerger disease.

  5. Publications - Sabrina Correa da Costa, M.D. - Mayo Clinic

    2025; 12(aRTICLE 2). Ghafouri M, Correa da Costa S, Zare Dehnavi A, Gold MS, Rummans TA. Treatments for Cannabis Use Disorder across the Lifespan: A Systematic ...

  6. Belladonna and opium (rectal route) - Side effects & dosage - Mayo Clinic

    Bromopride; Buprenorphine; Butalbital; Butorphanol; Calcium Oxybate; Cannabidiol; Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Cetirizine; Citalopram ...

  7. Aripiprazole (intramuscular route) - Side effects & uses - Mayo Clinic

    Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Celecoxib; Ceritinib; Cetirizine; Chlordiazepoxide. Show More. Using this medicine with any of the following ...

  8. Clorazepate (oral route) - Mayo Clinic

    Cannabis; Carbidopa; Carbinoxamine; Carisoprodol; Cetirizine; Chloral Hydrate; Chlorzoxazone; Clobazam; Clonazepam; Codeine; Dantrolene; Daridorexant ...

  9. Mayo Clinic Q and A: What is pharmacogenomics?

    ... cannabis products. Also, testing can guide therapy, optimizing medications to achieve the best outcomes. Your health care provider can use test results to ...

  10. 8 Week Multi-site Study of MYDAYIS® for Bipolar Depression - Mayo Clinic

    Positive toxicology screen for cannabis and a cannabis use disorder by structured clinical interview for DSM-IV-TR. Participants who use cannabis for ...